Related Experiment Video
Updated: May 25, 2026

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Published on: December 17, 2013
Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question
Rodrigo A Somoza1, Francisco J Rubio
1Laboratorio de Neurociencias, Universidad de los Andes, Las Condes, Santiago, Chile.
Mesenchymal stem cells (MSC) offer a promising alternative to embryonic stem cells (ES) for human therapies. Their epigenetic plasticity and diverse sources make them suitable for treating various conditions, potentially overcoming challenges associated with ES and induced pluripotent stem cells (iPS).
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Cellular Therapy
Background:
- Ethical concerns and technical challenges limit the use of embryonic stem cells (ES) in human therapies.
- Somatic stem cells (SSC), including mesenchymal stem cells (MSC), are involved in tissue regeneration and homeostasis.
- Induced pluripotent stem cells (iPS) are generated from mature cells but require overexpression of specific factors.
Purpose of the Study:
- To review cellular tools for human therapy.
- To analyze the potential and requirements of mesenchymal stem cells (MSC) and induced pluripotent stem cells (iPS).
- To highlight the advantages of using MSC over iPS in therapeutic strategies.
Main Methods:
- Review of existing literature on stem cell therapies.
- Analysis of stem cell plasticity, proliferation, and differentiation.
- Comparison of mesenchymal stem cells (MSC) and induced pluripotent stem cells (iPS) for therapeutic applications.
Main Results:
- Mesenchymal stem cells (MSC) exhibit epigenetic plasticity, allowing differentiation into various cell types.
- MSC can be sourced from diverse locations, enhancing their suitability for therapeutic use.
- MSC present potential advantages over iPS in terms of safety and efficacy for certain applications.
Conclusions:
- Mesenchymal stem cells (MSC) show significant therapeutic potential, offering an alternative to embryonic stem cells (ES) and induced pluripotent stem cells (iPS).
- Further research into MSC-derived therapies is warranted to address challenges in cell fate regulation and in vivo signaling.
- MSC-based strategies may offer a safer and more viable approach for regenerative medicine.
More Related Videos
13:58Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
Published on: July 29, 2015
10:52Isolation of Adult Human Dermal Fibroblasts from Abdominal Skin and Generation of Induced Pluripotent Stem Cells Using a Non-Integrating Method
Published on: January 19, 2020
Related Concept Videos
Stem Cell Culture
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...